In addition, patients hospitalized with COVID-19 and increased urinary biomarkers, such as neutrophil gelatinase-associated lipocalin, monocyte chemoattractant protein, and kidney injury molecule 1, are at high risk of adverse kidney outcomes and death [40,41]. This evidence concerns the gene LCN2 and COVID-19.